Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
Product Unit Size | Cost | Quantity | Stock |
---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
Purity | ≥95% |
---|---|
Formula | C18H25N5O5S |
Formula Wt. | 423.4 |
Synonym | MGP-pNa |
Solubility | Soluble in water. |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Microtubule depolymerization inhibitor.
σ2 agonist.
STING antagonist
β-lactam carbapenem; penicillin binding protei...
Glycopeptide, binds D-Ala-D-Ala; cell wall synt...
AChE inhibitor.
Cysteine-ITC conjugate, antioxidant; aldehyde d...
Synthetic derivative of vasicine, mucolytic.
Catalyzes hydrolysis of asparagine.
MDM2-p53 inhibitor
Endogenous peptide hormone, involved in secreti...
Endogenous APP peptide cleavage product, primar...
CDK inhibitor, L-type Ca2+ channel blocker.
p53 inhibitor
5-HT2A and TRPV1 antagonist, potential α1-adre...
Cephalomannine derivative found in Taxus; poten...
RAF inhibitor.
Polypeptide; serine protease inhibitor.
Neurotoxin frequently used to aid in modeling P...
Endogenous opioid peptide derived from the β-c...